Dendreon Stock Price, News & Analysis (OTCMKTS:DNDNQ)

$0.03 0.00 (0.00 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$0.03
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$5.45 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Dendreon (OTCMKTS:DNDNQ)

Dendreon logoDendreon Corporation, is a biotechnology company. The Company is focused on discovery, development and commercialization of therapeutics for cancer treatment. The Company’s product portfolio includes cellular immunotherapies and small molecule product candidate that could be applicable to treating multiple types of cancers. The Company’s product PROVENGE (sipuleucel-T), is an autologous cellular immunotherapy for the treatment of asymptomatic and minimally symptomatic, metastatic, castrate-resistant hormone-refractory prostate cancer. Other potential product candidates include investigational active cellular immunotherapy, which potentially may be used for the treatment of patients with bladder, breast, ovarian and other solid tumors expressing HER2/neu; active cellular immunotherapies directed at carbonic anhydrase 9, an antigen highly expressed in renal cell carcinoma, and carcinoembryonic antigen, an antigen expressed in colorectal and other cancers.


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: N/A
  • Symbol: OTCMKTS:DNDNQ
  • Previous Symbol: NASDAQ:DNDN
  • CUSIP: N/A
  • Web: www.dendreon.com
Profitability:
  • Trailing EPS: ($1.06)
  • Net Margins: -30.18%
  • Return on Assets: -25.12%
 
Frequently Asked Questions for Dendreon (OTCMKTS:DNDNQ)

What is Dendreon's stock symbol?

Dendreon trades on the OTCMKTS under the ticker symbol "DNDNQ."

How were Dendreon's earnings last quarter?

Dendreon Co. (OTCMKTS:DNDNQ) announced its quarterly earnings data on Monday, November, 10th. The biotechnology company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.04. The biotechnology company had revenue of $73.10 million for the quarter, compared to the consensus estimate of $78.72 million. Dendreon's revenue for the quarter was up 7.5% on a year-over-year basis. During the same period in the previous year, the business posted ($0.44) earnings per share. View Dendreon's Earnings History.

Who are some of Dendreon's key competitors?

How do I buy Dendreon stock?

Shares of Dendreon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dendreon's stock price today?

One share of Dendreon stock can currently be purchased for approximately $0.03.

How big of a company is Dendreon?

Dendreon has a market capitalization of $5.45 million.

How can I contact Dendreon?

Dendreon's mailing address is 601 Union St Ste 4900, SEATTLE, WA 98101-3906, United States. The biotechnology company can be reached via phone at +1-206-2197815.


MarketBeat Community Rating for Dendreon (OTCMKTS DNDNQ)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  45
MarketBeat's community ratings are surveys of what our community members think about Dendreon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Dendreon (OTCMKTS:DNDNQ) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A
Consensus Price Target History for Dendreon (OTCMKTS:DNDNQ)
Price Target History for Dendreon (OTCMKTS:DNDNQ)
Analysts' Ratings History for Dendreon (OTCMKTS:DNDNQ)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Dendreon (OTCMKTS:DNDNQ)
Earnings by Quarter for Dendreon (OTCMKTS:DNDNQ)
Earnings History by Quarter for Dendreon (OTCMKTS DNDNQ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2014Q3($0.10)($0.14)$78.72 million$73.10 millionViewN/AView Earnings Details
8/20/2014($0.18)($0.18)ViewN/AView Earnings Details
8/11/2014($0.25)($0.10)$73.37 million$82.16 millionViewN/AView Earnings Details
5/8/2014Q114($0.28)($0.24)$69.19 million$68.70 millionViewListenView Earnings Details
3/3/2014Q413($0.37)($0.17)$73.59 million$74.80 millionViewListenView Earnings Details
11/12/2013Q313($0.42)($0.44)$76.60 million$68.00 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.42)($0.45)$75.61 million$73.30 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.47)($0.48)$80.15 million$67.60 millionViewN/AView Earnings Details
2/25/2013Q4 2012($0.56)($0.26)$82.88 million$85.49 millionViewN/AView Earnings Details
11/2/2012Q312($0.75)($0.33)$80.68 million$78.00 millionViewN/AView Earnings Details
5/2/2011($0.70)($0.77)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dendreon (OTCMKTS:DNDNQ)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Dendreon (OTCMKTS:DNDNQ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Dendreon (OTCMKTS DNDNQ)
Insider Trades by Quarter for Dendreon (OTCMKTS:DNDNQ)
Insider Trades by Quarter for Dendreon (OTCMKTS DNDNQ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/19/2015Karen BrophyVPSell6,132$0.07$429.24View SEC Filing  
2/18/2015Silvio PachecoSVPSell5,722$0.07$400.54View SEC Filing  
2/17/2015William MonteithEVPSell97,974$0.08$7,837.92View SEC Filing  
2/13/2015Andrew Seth SandlerEVPSell113,716$0.09$10,234.44View SEC Filing  
2/13/2015Greg CoxCFOSell114,154$0.09$10,273.86View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Dendreon (OTCMKTS:DNDNQ)
Latest Headlines for Dendreon (OTCMKTS DNDNQ)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social Media

Financials

Financials are not available for this stock.

Chart

Dendreon (OTCMKTS DNDNQ) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.